Acta Med. 2010, 53: 225-228
https://doi.org/10.14712/18059694.2016.81
Plasma Interleukin-6 Level is Associated with NT-proBNP Level and Predicts Short- and Long Term Mortality in Patients with Acute Heart Failure
References
1. A, Petersen N, Feldman A, Young J, White B, Mann D. Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the vesnarinone trial. Circulation 2001; 103: 2055–2059.
<https://doi.org/10.1161/01.CIR.103.16.2055>
2. A, Pathegini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006; 179–187.
<https://doi.org/10.1016/j.cca.2006.02.042>
3. A, MBch B. Cytokines and Myocardial Dysfunction: State of Art. J Cardiac Fail 2008; 14: 61–64.
<https://doi.org/10.1016/j.cardfail.2007.09.006>
4. D, Assad-Kottner C, Orrego C, Torre-Amione G. Cytokines and acute heart failure. Crit Care Med. 2008;36(1 Suppl): S9–16.
<https://doi.org/10.1097/01.CCM.0000297160.48694.90>
5. JL, Camargo CA, Anwarudin S. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005; 95(8): 948–54.
<https://doi.org/10.1016/j.amjcard.2004.12.032>
6. O, Pettilot P, Labalette M. Cytokine profile of human septic shock serum inducing cardiomycyte contractile dysfunction. Physiol Res 2007; 56: 291–7.
7. PA, Ko DT, Newman AM, Palomaki GE et al. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem. 2007; 53(12): 2112–8.
<https://doi.org/10.1373/clinchem.2007.090613>
8. VC, Ramgolam VS, Bender J. Cytokines and cardiovascular disease. J Leukoc Biol 2005; 78: 805–818.
<https://doi.org/10.1189/jlb.0405182>
9. G, Braun S, Mehilli J, Schömig A, Kastrati A: Accuracy of N-Terminal Probrain Natriuretic Peptide to Predict Mortality or Detect Acute Ischemia in Patients with Coronary Artery Disease. Cardiology 2008; 109: 249–257.
<https://doi.org/10.1159/000107788>
10. N, Hemingway CA, Alizadeh AA. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363: 203–9.
<https://doi.org/10.1016/S0140-6736(03)15326-3>
11. JW, Felker GM. Inflammatory biomarkers in heart failure. Congest Heart Fail. 2006; 12(6): 324–8.
<https://doi.org/10.1111/j.1527-5299.2006.05595.x>
12. R, Krejsek J, Pidrman V, Gregor J, Tichy M, Bures J. Inflammatory response to acute myocardial infarction complicated by cardiogenic shock. Acta Medica (Hradec Kralove) 2001; 44 (4): 149–51.
13. SU, Januzzi JL jr. Natriuretic peptides for guiding heart failure therapy. Compr Ther. 2008; 34: 32–40.
14. H, Mohacsi P, Fuller-Bicer GA et al. Cytokine activation and disease progression in patients with stable moderate chronic heart failure. J Heart Lung Transplant. 2007; 26: 622–9.
<https://doi.org/10.1016/j.healun.2007.01.033>
15. T, Hisagana T, Wada A et al. Kinoshita M: Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998; 31: 391–8.
<https://doi.org/10.1016/S0735-1097(97)00494-4>
